Related Experiment Videos
Dopamine activates HIV in chronically infected T lymphoblasts
C Scheller1, S Sopper, C Jassoy
1Institute for Virology and Immunobiology, University of Würzburg, Federal Republic of Germany.
Journal of Neural Transmission (Vienna, Austria : 1996)
|July 19, 2001
Summary
Dopamine (DA) activates HIV infection in T-lymphoblasts by altering cellular redox states. Antioxidants like glutathione and N-acetylcysteine can reduce this DA-induced HIV activation, suggesting a link between oxidative stress and viral replication.
Area of Science:
- Neuroscience
- Immunology
- Virology
Background:
- HIV infection compromises the dopaminergic system.
- Dopaminergic substances have been shown to exacerbate brain pathology in simian models of HIV.
Purpose of the Study:
- To investigate the effect of dopamine (DA) on HIV infection in chronically infected T-lymphoblasts (ACH-2 cell line).
- To elucidate the underlying mechanism of DA-induced HIV activation.
Main Methods:
- ACH-2 cells were exposed to varying concentrations of dopamine (DA).
- Flow cytometry was used to measure HIV activation.
- Cells were co-treated with DA and antioxidants (glutathione, N-acetylcysteine) to assess mechanistic pathways.
Main Results:
- Dopamine (DA) induced a concentration-dependent activation of HIV in ACH-2 cells.
- Treatment with antioxidants (glutathione, N-acetylcysteine) attenuated DA-induced HIV activation.
- The findings suggest that changes in cellular redox state mediate DA's effect on HIV.
Conclusions:
- HIV activation is closely associated with intracellular oxidant/antioxidant balance.
- Excessive dopamine exposure may increase cellular susceptibility to HIV infection.
- Redox modulation offers a potential target for managing HIV activation.